Sigma Planning’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-12,594
Closed -$353K – 1279
2022
Q3
$353K Buy
12,594
+884
+8% +$27.4K 0.01% 884
2022
Q2
$353K Buy
+11,710
New +$402K 0.01% 909

Other funds holding BOUT

Sigma Planning's BOUT Position: Q4 2022 in Review

Sigma Planning sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2022, closing a stake of 12,594 shares — an estimated $353K sold.

Sigma Planning first reported a position in BOUT in Q2 2022 and held it in 2 quarters. The position peaked at $353K in Q3 2022. 8 funds tracked by Wall St. Rank hold BOUT as of Q4 2022.

  • Sigma Planning reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2022 after selling out during the quarter.
  • Sigma Planning sold 12,594 CapForce IBD Breakout Opportunities ETF shares in Q4 2022, an estimated $353K.
  • Sigma Planning first reported a position in CapForce IBD Breakout Opportunities ETF in Q2 2022 and held it in 2 quarters.
  • Sigma Planning's CapForce IBD Breakout Opportunities ETF position peaked at $353K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2022.

Based on Sigma Planning's 13F filing for Q4 2022, filed 24 Jan 2023.